Evidence map›Paper›PMID 35176118›Full record

ArticlePLoS pathogens2022

Total infectome characterization of respiratory infections in pre-COVID-19 Wuhan, China.

Mang Shi, Su Zhao, Bin Yu, Wei-Chen Wu, Yi Hu, Jun-Hua Tian, Wen Yin, Fang Ni, Hong-Ling Hu, Shuang Geng and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06566898 (Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06566898 recruitingnot on this mapstarted 2024, after this paper: background citation

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients: a Genomic Epidemiology Study

TypeobservationalSponsorShanghai General Hospital, ChinaRan2024 to 2026Enrolled800ConditionsPneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. RAPIDViruses · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Mang ShiZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Su ZhaoDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Bin YuWuhan Center for Disease Control and Prevention, Wuhan, China.
Wei-Chen WuZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yi HuDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun-Hua TianWuhan Center for Disease Control and Prevention, Wuhan, China.
Wen YinDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fang NiDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hong-Ling HuDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shuang GengDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li TanDepartment of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ying PengWuhan Center for Disease Control and Prevention, Wuhan, China.
Zhi-Gang SongZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wen WangZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yan-Mei ChenZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Edward C HolmesZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-9596-3552
Yong-Zhen ZhangZhongshan Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-5961-3691
Central Hospital of Wuhan · CNShanghai Public Health Clinical Center · CNWuhan Center for Disease Control and Prevention · CNThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the end of 2019 Wuhan witnessed an outbreak of "atypical pneumonia" that later developed into a global pandemic. Metagenomic sequencing rapidly revealed the causative agent of this outbreak to be a novel coronavirus denoted SARS-CoV-2. To provide a snapshot of the pathogens in pneumonia-associated respiratory samples from Wuhan prior to the emergence of SARS-CoV-2, we collected bronchoalveolar lavage fluid samples from 408 patients presenting with pneumonia and acute respiratory infections at the Central Hospital of Wuhan between 2016 and 2017. Unbiased total RNA sequencing was performed to reveal their "total infectome", including viruses, bacteria and fungi. We identified 35 pathogen species, comprising 13 RNA viruses, 3 DNA viruses, 16 bacteria and 3 fungi, often at high abundance and including multiple co-infections (13.5%). SARS-CoV-2 was not present. These data depict a stable core infectome comprising common respiratory pathogens such as rhinoviruses and influenza viruses, an atypical respiratory virus (EV-D68), and a single case of a sporadic zoonotic pathogen-Chlamydia psittaci. Samples from patients experiencing respiratory disease on average had higher pathogen abundance than healthy controls. Phylogenetic analyses of individual pathogens revealed multiple origins and global transmission histories, highlighting the connectedness of the Wuhan population. This study provides a comprehensive overview of the pathogens associated with acute respiratory infections and pneumonia, which were more diverse and complex than obtained using targeted PCR or qPCR approaches. These data also suggest that SARS-CoV-2 or closely related viruses were absent from Wuhan in 2016-2017.

Indexed as

Disease OutbreaksAcute DiseaseAdolescentAdultAgedAged, 80 and overBronchoalveolar Lavage FluidChinaCohort StudiesCOVID-19FemaleGene Expression ProfilingHumansMaleMetagenomicsMiddle Aged

Identifiers

PMID35176118
PMCPMC8853501
OpenAlexW4212894683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.